RptdFinFcst · v5.6 corrected pre-print · sealed snap-1408710-20260817T165607768286Z

FN FQ4-2026 + FY2026 — claude-fable-5 CONTRACT PASSED

Fiscal 2026 Q4 and full year (quarter ended June 26, 2026), announced Aug 17 after the close; results unreleased at the cutoff 2026-08-17T14:30:00Z. Three statements, a two-year quarterly path, and a thesis with falsifiable triggers — every identity re-added at intake, the balance sheet rolled from the model's own cash flow.

15tool calls
0contract retries
1anchor retries
0unverified anchors
298swall clock
278filings in corpus

Anchors stated before projecting

Each cites its filing; every anchor value was verified against the cited source at intake.

FQ3'26 revenue, $ thousands (3M ended 3/27/26)

1,214,293

0001408710-26-000014 · 0001408710-26-000014:fn-2026504xex991q326.htm:b0000043

FQ3'26 GAAP diluted EPS

3.45

0001408710-26-000014 · 0001408710-26-000014:fn-2026504xex991q326.htm:b0000010

FQ3'26 non-GAAP net income, $ thousands

134,864

0001408710-26-000014 · 0001408710-26-000014:fn-2026504xex991q326.htm:b0000064

Q4 FY26 revenue guidance low end, $ billions ($1.25B to $1.29B)

1.25

0001408710-26-000014 · 0001408710-26-000014:fn-2026504xex991q326.htm:b0000016

Q4 FY26 revenue guidance high end, $ billions

1.29

0001408710-26-000014 · 0001408710-26-000014:fn-2026504xex991q326.htm:b0000016

Q4 FY26 GAAP EPS guidance low end ($3.48 to $3.63)

3.48

0001408710-26-000014 · 0001408710-26-000014:fn-2026504xex991q326.htm:b0000017

Q4 FY26 non-GAAP EPS guidance low end ($3.72 to $3.87)

3.72

0001408710-26-000014 · 0001408710-26-000014:fn-2026504xex991q326.htm:b0000018

Q4 FY26 non-GAAP EPS guidance high end

3.87

0001408710-26-000014 · 0001408710-26-000014:fn-2026504xex991q326.htm:b0000018

9M FY26 net cash provided by operating activities, $ thousands

201,758

0001408710-26-000014 · 0001408710-26-000014:fn-2026504xex991q326.htm:b0000047

FQ3'26 net cash provided by operating activities, $ thousands

52,931

0001408710-26-000014 · 0001408710-26-000014:fn-2026504xex991q326.htm:b0000068

FQ3'26 purchase of property, plant and equipment, $ thousands

63,760

0001408710-26-000014 · 0001408710-26-000014:fn-2026504xex991q326.htm:b0000068

Cash, cash equivalents and restricted cash at 3/27/26, USD

357,256,000

0001408710-26-000016 · 0001408710-26-000016:fn-20260327.htm:b0000140

Total shareholders' equity at 3/27/26, $ thousands

2,304,711

0001408710-26-000014 · 0001408710-26-000014:fn-2026504xex991q326.htm:b0000039

Headline forecast

Revenue ($M) 1,282 p50 1,320 1,372 model guide mid 1,2701,2501,290company
Model p10–p50–p90 against the company's guided range.
Adjusted EPS (USD) 3.74 p50 3.88 4.10 model guide mid 3.793.723.87company
Model p10–p50–p90 against the company's guided range.
Free cash flow ($M) -35 p50 25 90 model
Model p10–p50–p90.

The income statement walk

Prior quarter as filed · forecast · change. ✓ = identity enforced at intake.

Line ($M)Prior as filedForecastΔ
Revenues1,2141,320+8.7%
Cost of revenues1,0701,162+8.6%
Gross profit ✓144158+9.7%
Selling, general and administrative expenses2426+5.0%
Restructuring and other related costs00+0.0%
Operating income ✓120133+10.7%
Interest and other income, net78+1.1%
Foreign exchange gain (loss), net71-85.7%
Other income (expense), net-0-0-5.7%
Income before income taxes ✓134141+5.2%
Income tax expense910+9.6%
Net income ✓125131+4.9%
Weighted average diluted shares3636+0.1%
Diluted EPS (GAAP) ✓3.453.61+4.6%

Bridge: net income 131 + share_based_comp_cost_of_revenues 3 + share_based_comp_sga 6 + severance_legal_and_litigation 0 = non-GAAP net income 141 ÷ 36M shares = 3.88 adjusted EPS.

The cash flow statement

As-reported sign conventions; free cash flow = CFO + capex; ✓ totals re-added at intake.

Line ($M)Prior as filedForecast
Net income125131
Depreciation and amortization1819
Share-based compensation89
Other operating adjustments incl. working capital, net (residual)-99-69
Net cash provided by operating activities ✓5390
Purchases of property, plant and equipment-64-65
Other investing incl. investment purchases/maturities, net (residual)5010
Net cash used in investing activities ✓-14-55
Repurchases of ordinary shares-0-0
Other financing incl. debt and taxes on RSUs, net (residual)-1-2
Net cash used in financing activities ✓-1-2
Effect of FX on cash and restricted cash-2-0
Net change in cash and restricted cash (derived total) ✓3732

The projected balance sheet

End of quarter. Cash rolls from the model's own cash flow; retained earnings roll from net income, dividends, and buybacks.

Line ($M)Prior as filedForecast
Cash, cash equivalents and restricted cash357390
All other assets (residual)3,1523,294
Total assets ✓3,5093,684
Total liabilities1,2041,245
Retained earnings2,4272,558
Common stock, paid-in capital and AOCI, net (residual)-122-120
Total shareholders' equity ✓2,3052,439

Expected next-period guidance

Revenue1,350 – 1,390
Adjusted EPS3.95 – 4.10

Quarterly path — where no guide exists

Beyond the guided quarter the model is modeling, not retrieving.

QuarterRev p50 ($M)Rev bandAdj EPS p50GMOMCapexFCF
fiscal 2027 Q1 (ending late September 2026)1,4001,330–1,4804.0812.0%10.1%-6050
fiscal 2027 Q2 (ending late December 2026)1,4801,390–1,5854.3012.0%10.1%-6060
fiscal 2027 Q3 (ending late March 2027)1,5401,420–1,6654.4712.0%10.2%-7060
fiscal 2027 Q4 (ending late June 2027)1,6001,450–1,7554.6312.0%10.2%-7070

Fiscal-year horizons — absolute forecasts, tracked as vintages

Fiscal yearRev p50 ($M)Rev bandAdj EPS p50EPS bandCapexFCF
fiscal year 2026 (ended June 2026 — reported at this release)4,6454,607–4,69713.8713.73–14.09-22666
fiscal year 2027 (ending June 2027)6,0205,580–6,50017.4015.90–19.20-260240
fiscal year 2028 (ending June 2028)7,0006,250–7,80019.9017.30–22.80-280360
fiscal year 2029 (ending June 2029)7,8006,800–8,90022.0018.30–25.80-300460

Thesis — commitments and triggers, all fundamentals

Every commitment cites a source and names the forecast lines it flows into; every trigger is an observable reported fundamental with its check date. Triggers are re-served to the next run for review.

CEO: 'several new customer agreements, particularly in the datacom market, to further strengthen our growth trajectory as we move into the fourth quarter and beyond' — datacom re-acceleration on top of telecom/DCI strength

0001408710-26-000014:fn-2026504xex991q326.htm:b0000005 · horizon FQ4'26 through FY27

flows into: income_statement.revenue, quarterly_path.fq1_27.revenue, horizons.fy1.revenue

Capacity expansion underway: 9M FY26 capex of $160.6M (vs $70.7M prior year) plus $65.3M of fixed-asset payables — Building 10 in Chonburi and US footprint build-out continue into FY27

0001408710-26-000014:fn-2026504xex991q326.htm:b0000047 · horizon FY26-FY28

flows into: cash_flow.capex, horizons.fy1.capex, horizons.fy2.capex

Inventory build of $297M in 9M FY26 ahead of program ramps — pre-positioned materials convert to revenue and then to cash as ramps mature, normalizing working capital

0001408710-26-000014:fn-2026504xex991q326.htm:b0000047 · horizon FQ4'26-FY27

flows into: cash_flow.cfo, cash_flow.other_operating, horizons.fy1.cfo

Non-GAAP definition excludes SBC, severance, legal/litigation and restructuring; guided bridge of $0.24/share for Q4

0001408710-26-000014:fn-2026504xex991q326.htm:b0000072 · horizon FQ4'26

flows into: bridge.non_gaap_net_income, headline.eps_adjusted

Debt-free balance sheet with $945.9M cash+investments and an ongoing share repurchase program (9M buybacks $5.2M) supporting opportunistic returns

0001408710-26-000014:fn-2026504xex991q326.htm:b0000039 · horizon FY27-FY29

flows into: cash_flow.buybacks, horizons.fy1.cff, horizons.fy1.total_equity

What would make it a buyer

Q4 revenue ≥ $1.32B with datacom revenue re-accelerating sequentially (above FQ3's $260.4M), confirming the new 1.6T/datacom program ramps

checkable at: Q4 FY26 8-K earnings release and investor presentation product-category table (Aug 2026)

FY27 Q1 CFO ≥ $100M with inventory growth slowing below revenue growth (working-capital conversion beginning)

checkable at: Q1 FY27 8-K cash flow statement (Nov 2026)

Non-GAAP operating margin ≥ 11.0% on >$1.4B quarterly revenue, evidence of scale leverage above the 10.5-10.7% band

checkable at: Q1/Q2 FY27 8-K non-GAAP reconciliation

What would make it a seller

Q1 FY27 revenue guidance below $1.30B (sequential decline), signaling a pause in datacom/DCI ramps or an inventory-digestion phase at the lead AI customer

checkable at: Q4 FY26 8-K Business Outlook section (Aug 2026)

Non-GAAP gross margin below 11.6% for two consecutive quarters (ramp inefficiency plus Thai baht strength overwhelming pricing)

checkable at: Q1 and Q2 FY27 8-K non-GAAP reconciliations

Inventories rising above $1.1B while quarterly revenue growth falls below 5% sequentially, or FY27 FCF running below $50M/quarter after FQ2'27

checkable at: FY27 10-Qs balance sheet and cash flow statements

What must be true: The AI-driven optical cycle (1.6T datacom transceivers, DCI/telecom systems, HPC assemblies) must continue ramping through FY27 with Fabrinet retaining sole/lead manufacturing positions at its top customers (NVIDIA, Cisco, Lumentum, Ciena, Amazon programs); gross margin must hold near 12% despite ramp costs and baht exposure; and the $300M+ working-capital investment must convert to cash as programs mature rather than signal demand overshoot.

Preview note, verbatim

FN reports Q4 FY26 (June-quarter) after beating the high end of guidance in each of the last several quarters. Guidance is $1.25-1.29B revenue and $3.72-3.87 non-GAAP EPS; we model $1,320M and $3.88 — another modest beat driven by the 1.6T datacom ramp (CEO flagged 'several new customer agreements, particularly in datacom'), continued DCI momentum ($196.9M in Q3, +38% q/q), and HPC scaling ($106.7M in Q3 from zero a year ago). Three things matter: (1) datacom trajectory — the segment has been flat-to-down ($260M in Q3) while telecom carried growth; evidence the new programs are converting is the single biggest driver of the FY27 outlook; (2) gross margin — GAAP GM slipped to 11.9% in Q3 on ramp costs; holding ~12% on 9% sequential growth would confirm scale leverage; (3) cash conversion — 9M FCF of just $41M on a $297M inventory build; a Q4 CFO print near $90M+ would show working capital cresting. The reaction will hinge less on the Q4 print than on Q1 FY27 guidance: we expect $1.35-1.39B revenue and $3.95-4.10 non-GAAP EPS. A guide implying continued mid-single-digit sequential growth with stable margins keeps the AI-optics thesis intact; a flat guide or margin walk-down would hit the stock hard given expectations embedded after a +39% y/y Q3.

Full model reasoning (verbatim)

Revenue: FN beat its guidance high end in FQ2 (printed $1,133M) and FQ3 ($1,214M, +39% y/y). Q4 guide is $1.25-1.29B; given ramping 1.6T datacom, DCI (+38% q/q in Q3), HPC, and the CEO's explicit new-agreement commentary, I model $1,320M (+8.7% q/q), ~2% above the high end — consistent with the recent beat cadence but tempered because sequential adds moderated from +$155M (Q2) to +$81M (Q3). Margins: GAAP GM 12.0% (Q3 11.9%, Q2 12.2%); SG&A $25.5M; GAAP op margin 10.1%, non-GAAP ~10.7% (matching Q3 and the guidance framework). Below the line: interest income $7.5M, FX +$1.0M (unpredictable; Q3 +$7.0M, long-run near zero), tax ~7% (9M rate 6.1%, Q4 typically slightly higher). GAAP NI $131.3M → $3.61 EPS on 36.35M shares. Bridge: SBC $9.1M plus ~$0.5M severance/legal → non-GAAP NI $140.9M → $3.88, just above the guided high of $3.87. Cash flow: working-capital drag eases from Q3's extreme (-$98.6M other-operating) but AR grows with revenue; CFO $90M, capex $65M (elevated expansion run-rate), FCF $25M; ST-investment maturities net +$10M; minimal buybacks. Balance sheet rolls forward mechanically: cash $389.5M, retained earnings $2,558.1M, equity $2,438.6M, liabilities $1,245M (AP growth with volume). FY27: I model +30% growth to $6.02B — slower than FY26's +36% but sustained by full-year contribution of new datacom programs, DCI, and HPC; margins held at ~12.0% GAAP GM / 10.2% GAAP OM with slight leverage; working capital normalizes, lifting CFO to ~$500M and FCF to ~$240M despite $260M capex. FY28/FY29 decelerate to +16%/+11% as the 1.6T cycle matures and comps steepen, with FCF conversion improving as capex plateaus. Key risks to my p50: customer inventory digestion in AI optics (downside), faster-than-expected 1.6T/HPC ramp or co-packaged-optics-related share gains (upside).

Sealed as snap-1408710-20260817T165607768286Z over corpus manifest 4678dd1f… (278 filings, five-year window). Replay: python -m rff.filing.snapshot --replay snap-1408710-20260817T165607768286Z. Prompt v5.6. Nothing here is investment advice.